Evidence map›Paper›PMID 36781474›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2023

Tumor selective Ru(III) Schiff bases complexes with strong in vitro activity toward cisplatin-resistant MDA-MB-231 breast cancer cells.

Marijana Pavlović, Emira Kahrović, Sandra Aranđelović, Siniša Radulović, Predrag-Peter Ilich, Sanja Grgurić-Šipka, Nevzeta Ljubijankić, Dijana Žilić, Jurica Jurec

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Marijana PavlovićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia.
Emira KahrovićLaboratory for Inorganic and Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, University of Sarajevo, Zmaja od Bosne 33, 71 000, Sarajevo, Bosnia and Herzegovina. emira_kahrovic@yahoo.com.
Sandra AranđelovićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia.
Siniša RadulovićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia.
Predrag-Peter IlichDepartment of Natural Sciences, Weissman School of Arts and Sciences, Baruch College/CUNY, New York City, NY, USA.
Sanja Grgurić-ŠipkaFaculty of Chemistry, University of Belgrade, Studentski Trg 12-16, Belgrade, Serbia.
Nevzeta LjubijankićLaboratory for Inorganic and Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, University of Sarajevo, Zmaja od Bosne 33, 71 000, Sarajevo, Bosnia and Herzegovina.
Dijana ŽilićRuđer Bošković Institute, Bijenička 54, Zagreb, Croatia.
Jurica JurecRuđer Bošković Institute, Bijenička 54, Zagreb, Croatia.
Oncology Institute of Vojvodina · RSRudjer Boskovic Institute · HRUniversity of Sarajevo · BABaruch College · USUniversity of Belgrade · RS

Funding

NSF XSEDE MCB140083The Federal Ministry of Education and Science of Bosnia and Herzegovina 05-39-2619-1/18the Ministry of Education, Science and Technological Development of the Republic of Serbia 451-03-68/2022-14/200043the Ministry of Education, Science and Technological Development of the Republic of Serbia III 41026
6 · The paper itself

Abstract

Novel ruthenium(III) complexes of general formula Na[RuCl

Indexed as

Antineoplastic AgentsBreast NeoplasmsCell Line, TumorCisplatinCoordination ComplexesFemaleHumansRutheniumSchiff BasesAntineoplastic AgentsCisplatinCoordination ComplexesRutheniumSchiff BasesApoptosisBreast cancerCytoselectivityRu(III)Schiff bases

Identifiers

PMID36781474
OpenAlexW4320482392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.